应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
QNCX Quince Therapeutics, Inc.
休市中 07-18 16:00:00 EDT
1.89
+0.06
+3.28%
盘后
1.92
+0.03
+1.59%
19:30 EDT
最高
1.97
最低
1.77
成交量
15.98万
今开
1.82
昨收
1.83
日振幅
10.93%
总市值
8,594万
流通市值
6,461万
总股本
4,547万
成交额
30.11万
换手率
0.47%
流通股本
3,418万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Quince Therapeutics, Inc.盘中异动 下午盘股价大涨6.31%报1.10美元
市场透视 · 05-22
Quince Therapeutics, Inc.盘中异动 下午盘股价大涨6.31%报1.10美元
Quince Therapeutics, Inc.2025财年第一财季实现净利润-15.03百万美元,同比减少34.80%
市场透视 · 05-18
Quince Therapeutics, Inc.2025财年第一财季实现净利润-15.03百万美元,同比减少34.80%
Quince Therapeutics, Inc.盘中异动 早盘股价大跌5.46%报0.796美元
市场透视 · 05-15
Quince Therapeutics, Inc.盘中异动 早盘股价大跌5.46%报0.796美元
Quince Therapeutics, Inc.盘中异动 早盘股价大跌5.24%报0.900美元
市场透视 · 05-14
Quince Therapeutics, Inc.盘中异动 早盘股价大跌5.24%报0.900美元
Quince Therapeutics, Inc.盘中异动 快速下挫5.31%
市场透视 · 04-30
Quince Therapeutics, Inc.盘中异动 快速下挫5.31%
Quince Therapeutics, Inc.盘中异动 早盘股价大跌7.55%
市场透视 · 04-23
Quince Therapeutics, Inc.盘中异动 早盘股价大跌7.55%
Quince Therapeutics, Inc.盘中异动 大幅跳水5.30%报1.43美元
市场透视 · 03-10
Quince Therapeutics, Inc.盘中异动 大幅跳水5.30%报1.43美元
Quince Therapeutics, Inc.盘中异动 急速上涨5.67%
市场透视 · 02-19
Quince Therapeutics, Inc.盘中异动 急速上涨5.67%
Quince Therapeutics, Inc.盘中异动 股价大涨5.00%
市场透视 · 02-18
Quince Therapeutics, Inc.盘中异动 股价大涨5.00%
Quince Therapeutics, Inc.盘中异动 下午盘快速上涨5.00%报1.47美元
市场透视 · 02-13
Quince Therapeutics, Inc.盘中异动 下午盘快速上涨5.00%报1.47美元
Quince Therapeutics, Inc.盘中异动 早盘快速跳水5.41%
市场透视 · 02-10
Quince Therapeutics, Inc.盘中异动 早盘快速跳水5.41%
D. Boral Capital:维持Quince Therapeutics(QNCX.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。
金融界 · 02-05
D. Boral Capital:维持Quince Therapeutics(QNCX.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。
Quince Therapeutics, Inc.股价重挫14.46% 市值跌192.58万美元
市场透视 · 01-21
Quince Therapeutics, Inc.股价重挫14.46% 市值跌192.58万美元
Quince Therapeutics, Inc.盘中异动 股价大涨5.71%
市场透视 · 2024-12-18
Quince Therapeutics, Inc.盘中异动 股价大涨5.71%
Quince Therapeutics, Inc.盘中异动 早盘快速上涨5.39%报2.15美元
市场透视 · 2024-12-10
Quince Therapeutics, Inc.盘中异动 早盘快速上涨5.39%报2.15美元
Quince Therapeutics, Inc.盘中异动 快速跳水5.00%
市场透视 · 2024-12-05
Quince Therapeutics, Inc.盘中异动 快速跳水5.00%
Quince Therapeutics, Inc.盘中异动 早盘急速下挫5.09%
市场透视 · 2024-12-04
Quince Therapeutics, Inc.盘中异动 早盘急速下挫5.09%
Quince Therapeutics, Inc.2024财年第三财季实现净利润-5.49百万美元,同比减少2.62%
市场透视 · 2024-11-22
Quince Therapeutics, Inc.2024财年第三财季实现净利润-5.49百万美元,同比减少2.62%
Quince Therapeutics, Inc.盘中异动 急速上涨5.71%报1.85美元
市场透视 · 2024-11-19
Quince Therapeutics, Inc.盘中异动 急速上涨5.71%报1.85美元
Quince Therapeutics, Inc.盘中异动 急速拉升5.62%
市场透视 · 2024-11-18
Quince Therapeutics, Inc.盘中异动 急速拉升5.62%
加载更多
公司概况
公司名称:
Quince Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Quince Therapeutics, Inc.于2012年6月20日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,开创了一种新型疾病改善治疗方法,用于治疗被认为是阿尔茨海默氏症和退行性疾病的关键根本原因。该公司的方法是基于在迄今通过多项研究观察到的100多名阿尔茨海默病患者的大脑中,超过90%的人的大脑中发现了牙龈porphyromonas gingivalis或P. gingivalis及其分泌的毒性毒力因子蛋白酶,称为gingipains的开创性发现。此外,该公司在动物模型中观察到牙龈假单胞菌感染会导致阿尔茨海默病理学,这些影响已在临床前研究中成功地用牙龈痛抑制剂治疗。公司专有先导候选药物COR388是一种口服给药、可穿透脑的小分子牙龈痛抑制剂。COR388在迄今为止进行的1a期和1b期临床试验中具有良好的耐受性,没有相关的安全信号,该试验共招募了67名受试者,其中包括9名轻度至中度阿尔茨海默病患者。
发行价格:
--
{"stockData":{"symbol":"QNCX","market":"US","secType":"STK","nameCN":"Quince Therapeutics, Inc.","latestPrice":1.89,"timestamp":1752868800000,"preClose":1.83,"halted":0,"volume":159776,"hourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.89,"latestTime":"19:30 EDT","volume":294,"amount":548.63,"timestamp":1752881412357},"delay":0,"floatShares":34183352,"shares":45468800,"eps":-1.395769,"marketStatus":"休市中","change":0.06,"latestTime":"07-18 16:00:00 EDT","open":1.82,"high":1.97,"low":1.77,"amount":301064.271107,"amplitude":0.10929,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.395769,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":1.83,"preHourTrading":{"tag":"盘前","latestPrice":1.8999,"preClose":1.83,"latestTime":"08:47 EDT","volume":400,"amount":759.63,"timestamp":1752842851065},"postHourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.89,"latestTime":"19:30 EDT","volume":294,"amount":548.63,"timestamp":1752881412357},"volumeRatio":0.5791544638288751,"impliedVol":1.9139,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/QNCX","defaultTab":"news","newsList":[{"id":"2537264739","title":"Quince Therapeutics, Inc.盘中异动 下午盘股价大涨6.31%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537264739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537264739?lang=zh_cn&edition=full","pubTime":"2025-05-23 01:27","pubTimestamp":1747934826,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日01时27分,Quince Therapeutics, Inc.股票出现异动,股价大幅上涨6.31%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.55%。其相关个股中,Vigil Neuroscience, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Instil Bio, Inc.涨幅较大,Polyrizon Ltd.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃,换手率分别为4774.76%、2337.44%、1039.84%,振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为92.76%、64.32%、60.20%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的精准治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523012706a6e9275a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523012706a6e9275a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2536594866","title":"Quince Therapeutics, Inc.2025财年第一财季实现净利润-15.03百万美元,同比减少34.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594866","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594866?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584098,"startTime":"0","endTime":"0","summary":"5月19日,Quince Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为-15.03百万美元,同比减少34.80%;其中营业收入为0.00美元,每股基本收益为-0.34美元。机构评级:截至2025年5月19日,当前有4家机构对Quince Therapeutics, Inc.目标价做出预测,其中目标均价为7.25美元,其中最低目标价为4.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000601a482f176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000601a482f176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ"],"gpt_icon":0},{"id":"2535482792","title":"Quince Therapeutics, Inc.盘中异动 早盘股价大跌5.46%报0.796美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535482792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535482792?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:59","pubTimestamp":1747321146,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时59分,Quince Therapeutics, Inc.股票出现波动,股价快速下挫5.46%。截至发稿,该股报0.796美元/股,成交量6.3842万股,换手率0.14%,振幅8.32%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.50%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的精准治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515225906a47fbb3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515225906a47fbb3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","QNCX","LENZ","BK4007"],"gpt_icon":0},{"id":"2535646020","title":"Quince Therapeutics, Inc.盘中异动 早盘股价大跌5.24%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535646020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535646020?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:38","pubTimestamp":1747229881,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时38分,Quince Therapeutics, Inc.股票出现波动,股价快速下跌5.24%。截至发稿,该股报0.900美元/股,成交量3.8553万股,换手率0.09%,振幅5.26%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的精准治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421380194f6c8e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421380194f6c8e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","QNCX","BK4539","LENZ"],"gpt_icon":0},{"id":"2532670120","title":"Quince Therapeutics, Inc.盘中异动 快速下挫5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532670120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532670120?lang=zh_cn&edition=full","pubTime":"2025-05-01 03:23","pubTimestamp":1746041008,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日03时23分,Quince Therapeutics, Inc.股票出现异动,股价大幅下跌5.31%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.44%。其相关个股中,Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Abeona Therapeutics Inc.涨幅较大,Purple Biotech Ltd、Processa Pharmaceuticals, Inc.、Regulus Therapeutics Inc.较为活跃,换手率分别为165.40%、44.62%、39.30%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Abeona Therapeutics Inc.、Xtl生物制药,振幅分别为64.00%、37.52%、36.63%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的精准治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501032328974be113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501032328974be113&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","LENZ","BK4007"],"gpt_icon":0},{"id":"2529681139","title":"Quince Therapeutics, Inc.盘中异动 早盘股价大跌7.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529681139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529681139?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:45","pubTimestamp":1745415936,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时45分,Quince Therapeutics, Inc.股票出现异动,股价急速下跌7.55%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。其相关个股中,Ensysce Biosciences, Inc.、Instil Bio, Inc.、Silexion Therapeutics Corp涨幅较大,Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Ocean Biomedical, Inc.较为活跃,换手率分别为4304.82%、27.92%、26.71%,振幅较大的相关个股有Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Ocean Biomedical, Inc.,振幅分别为52.94%、41.41%、33.25%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的精准治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423214536974236af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423214536974236af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","QNCX","LENZ","BK4139"],"gpt_icon":0},{"id":"2518202735","title":"Quince Therapeutics, Inc.盘中异动 大幅跳水5.30%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518202735?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:18","pubTimestamp":1741634284,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时18分,Quince Therapeutics, Inc.股票出现波动,股价大幅下跌5.30%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.46%。其相关个股中,Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃,换手率分别为6316.63%、3862.24%、1024.29%,振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为90.44%、88.14%、72.15%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031804abf37cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031804abf37cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","BK4139","LENZ"],"gpt_icon":0},{"id":"2512370483","title":"Quince Therapeutics, Inc.盘中异动 急速上涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512370483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512370483?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975484,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分,Quince Therapeutics, Inc.股票出现波动,股价大幅拉升5.67%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Osr Holdings, Inc.、Allogene Therapeutics, Inc.、Aditxt, Inc.涨幅较大,Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃,换手率分别为204.04%、202.00%、65.54%,振幅较大的相关个股有Allogene Therapeutics, Inc.、Azitra Inc、Osr Holdings, Inc.,振幅分别为31.34%、11.29%、10.29%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223124a24bf93b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223124a24bf93b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","LENZ"],"gpt_icon":0},{"id":"2512660351","title":"Quince Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512660351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512660351?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889060,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分,Quince Therapeutics, Inc.股票出现异动,股价大幅上涨5.00%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大,Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为275.19%、90.58%、58.67%,振幅较大的相关个股有Allakos Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.,振幅分别为6.84%、6.43%、6.13%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231009889fc5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182231009889fc5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","QNCX","BK4139"],"gpt_icon":0},{"id":"2511575105","title":"Quince Therapeutics, Inc.盘中异动 下午盘快速上涨5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511575105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511575105?lang=zh_cn&edition=full","pubTime":"2025-02-14 02:14","pubTimestamp":1739470443,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日02时14分,Quince Therapeutics, Inc.股票出现异动,股价快速上涨5.00%。截至发稿,该股报1.47美元/股,成交量9.5076万股,换手率0.22%,振幅6.67%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.88%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214021403abcddd8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214021403abcddd8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","QNCX"],"gpt_icon":0},{"id":"2510986161","title":"Quince Therapeutics, Inc.盘中异动 早盘快速跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510986161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510986161?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:28","pubTimestamp":1739201329,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时28分,Quince Therapeutics, Inc.股票出现波动,股价快速跳水5.41%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃,换手率分别为2546.55%、1506.14%、953.59%,振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Immatics N V C/Wts 01/07/2025 ,振幅分别为69.83%、66.09%、50.50%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023284998808456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023284998808456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","QNCX"],"gpt_icon":0},{"id":"2509676407","title":"D. Boral Capital:维持Quince Therapeutics(QNCX.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509676407","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509676407?lang=zh_cn&edition=full","pubTime":"2025-02-05 20:11","pubTimestamp":1738757515,"startTime":"0","endTime":"0","summary":"D. Boral Capital:维持Quince Therapeutics(QNCX.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05201147968474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","QNCX"],"gpt_icon":0},{"id":"2505971271","title":"Quince Therapeutics, Inc.股价重挫14.46% 市值跌192.58万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505971271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505971271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:32","pubTimestamp":1737469934,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时32分,Quince Therapeutics, Inc.股票出现异动,股价快速下挫14.46%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.81%。其相关个股中,Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Dogwood Therapeutics, Inc.、Replimune Group, Inc.涨幅较大,Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃,换手率分别为530.12%、161.41%、28.48%,振幅较大的相关个股有Allakos Inc.、Cellectis Ads Each Repr 1 Ord Spon、Equillium, Inc.,振幅分别为111.05%、107.43%、107.00%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223214986e32ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223214986e32ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","QNCX"],"gpt_icon":0},{"id":"2492181805","title":"Quince Therapeutics, Inc.盘中异动 股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492181805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492181805?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:32","pubTimestamp":1734532361,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时32分,Quince Therapeutics, Inc.股票出现波动,股价大幅拉升5.71%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,Cognition Therapeutics, Inc.、Polyrizon Ltd.、Tc Biopharm Plc涨幅较大,Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1008.78%、299.12%、240.76%,振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Polyrizon Ltd.,振幅分别为66.83%、37.37%、24.76%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223241ab8206e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218223241ab8206e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ","BK4139"],"gpt_icon":0},{"id":"2490012080","title":"Quince Therapeutics, Inc.盘中异动 早盘快速上涨5.39%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490012080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490012080?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:31","pubTimestamp":1733841061,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时31分,Quince Therapeutics, Inc.股票出现波动,股价快速拉升5.39%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.25%。其相关个股中,Chimerix, Inc.、Uniqure N.V.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为1640.08%、398.07%、84.71%,振幅较大的相关个股有Silexion Therapeutics Corp、Glycomimetics, Inc.、Lantern Pharma Inc.,振幅分别为9.70%、8.97%、6.75%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022310195e8adf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121022310195e8adf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","BK4139","LENZ"],"gpt_icon":0},{"id":"2489466354","title":"Quince Therapeutics, Inc.盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489466354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489466354?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:44","pubTimestamp":1733413498,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时44分,Quince Therapeutics, Inc.股票出现异动,股价快速下挫5.00%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Protara Therapeutics, Inc.、Molecular Templates, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Psyence Biomedical Ltd.、Molecular Templates, Inc.、Protara Therapeutics, Inc.较为活跃,换手率分别为2244.15%、1499.46%、389.58%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Molecular Templates, Inc.,振幅分别为109.61%、105.08%、100.06%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234458ab6021b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205234458ab6021b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QNCX","LENZ","BK4139"],"gpt_icon":0},{"id":"2488519751","title":"Quince Therapeutics, Inc.盘中异动 早盘急速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488519751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488519751?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:30","pubTimestamp":1733322647,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时30分,Quince Therapeutics, Inc.股票出现波动,股价急速下挫5.09%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Eterna Therapeutics Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃,换手率分别为1166.71%、189.27%、109.36%,振幅较大的相关个股有Theratechnologies Inc.、Organovo Holdings, Inc.、Serina Therapeutics, Inc.,振幅分别为6.79%、5.30%、3.70%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223047a26c5d10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223047a26c5d10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","QNCX","BK4139"],"gpt_icon":0},{"id":"2485065298","title":"Quince Therapeutics, Inc.2024财年第三财季实现净利润-5.49百万美元,同比减少2.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485065298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485065298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291282,"startTime":"0","endTime":"0","summary":"11月23日,Quince Therapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-5.49百万美元,同比减少2.62%;其中营业收入为0.00美元,每股基本收益为-0.13美元。机构评级:截至2024年11月23日,当前有3家机构对Quince Therapeutics, Inc.目标价做出预测,其中目标均价为9.67美元,其中最低目标价为6.00美元,最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000154a24e48e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000154a24e48e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","QNCX"],"gpt_icon":0},{"id":"2484925425","title":"Quince Therapeutics, Inc.盘中异动 急速上涨5.71%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484925425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484925425?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:54","pubTimestamp":1732028074,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时54分,Quince Therapeutics, Inc.股票出现异动,股价急速上涨5.71%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.87%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Dermata Therapeutics Inc C/Wts 涨幅较大,Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃,换手率分别为680.61%、90.32%、74.97%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.,振幅分别为81.67%、52.14%、45.03%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922543598e4385b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111922543598e4385b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","QNCX","LENZ"],"gpt_icon":0},{"id":"2484567675","title":"Quince Therapeutics, Inc.盘中异动 急速拉升5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484567675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484567675?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940287,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分,Quince Therapeutics, Inc.股票出现波动,股价大幅上涨5.62%。Quince Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。其相关个股中,Hcw Biologics Inc.、冠科美博、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃,换手率分别为514.42%、179.03%、175.14%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Innate Pharma、Regenxbio Inc.,振幅分别为11.85%、10.42%、7.48%。Quince Therapeutics, Inc.公司简介:Quince Therapeutics Inc 是一家临床前阶段的生物制药公司,专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312798e433a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312798e433a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","QNCX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.quincetx.com","stockEarnings":[{"period":"1week","weight":0.0385},{"period":"1month","weight":0.3897},{"period":"3month","weight":0.9081},{"period":"6month","weight":0.1386},{"period":"1year","weight":1.52},{"period":"ytd","weight":0.0107}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Quince Therapeutics, Inc.于2012年6月20日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,开创了一种新型疾病改善治疗方法,用于治疗被认为是阿尔茨海默氏症和退行性疾病的关键根本原因。该公司的方法是基于在迄今通过多项研究观察到的100多名阿尔茨海默病患者的大脑中,超过90%的人的大脑中发现了牙龈porphyromonas gingivalis或P. gingivalis及其分泌的毒性毒力因子蛋白酶,称为gingipains的开创性发现。此外,该公司在动物模型中观察到牙龈假单胞菌感染会导致阿尔茨海默病理学,这些影响已在临床前研究中成功地用牙龈痛抑制剂治疗。公司专有先导候选药物COR388是一种口服给药、可穿透脑的小分子牙龈痛抑制剂。COR388在迄今为止进行的1a期和1b期临床试验中具有良好的耐受性,没有相关的安全信号,该试验共招募了67名受试者,其中包括9名轻度至中度阿尔茨海默病患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.051668},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.075156},{"month":3,"riseRate":0.5,"avgChangeRate":0.133761},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084014},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.087389},{"month":6,"riseRate":0.714286,"avgChangeRate":0.184618},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.059899},{"month":8,"riseRate":0.5,"avgChangeRate":0.047322},{"month":9,"riseRate":0.5,"avgChangeRate":0.013137},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.05998},{"month":11,"riseRate":0.5,"avgChangeRate":0.030681},{"month":12,"riseRate":0.333333,"avgChangeRate":0.106187}],"exchange":"NASDAQ","name":"Quince Therapeutics, Inc.","nameEN":"Quince Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Quince Therapeutics, Inc.(QNCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Quince Therapeutics, Inc.,QNCX,Quince Therapeutics, Inc.股票,Quince Therapeutics, Inc.股票老虎,Quince Therapeutics, Inc.股票老虎国际,Quince Therapeutics, Inc.行情,Quince Therapeutics, Inc.股票行情,Quince Therapeutics, Inc.股价,Quince Therapeutics, Inc.股市,Quince Therapeutics, Inc.股票价格,Quince Therapeutics, Inc.股票交易,Quince Therapeutics, Inc.股票购买,Quince Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Quince Therapeutics, Inc.(QNCX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Quince Therapeutics, Inc.(QNCX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}